PROCEPT BioRobotics (PRCT) stock: insider trades, news & valuation
Net buyingShare price and insider trades
PROCEPT BioRobotics insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $11.0M and 3 sold $624K of PRCT stock on the open market.
Get emailed when insiders cluster-buy stocks like PRCT
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PRCT insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $498K | 1 | $22K | 3 |
| Q2 2026 | — | 0 | $28K | 3 |
| Q1 2026 | $10.5M | 7 | $573K | 8 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 PROCEPT BioRobotics Corp insiders reported open-market purchases totaling $11.0M, while 3 insiders reported sales totaling $624K. 4 of 14 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 10SEC | Kevin WatersCFO | Sell | 373180,355 held (−0%) | $20.95 | $8K | -12.2% | — |
| Sep 10SEC | Barry L TemplinCTO | Sell | 37394,826 held (−0%) | $20.95 | $8K | -12.2% | — |
| Sep 10SEC | Alaleh NouriGeneral Counsel | Sell | 297127,737 held (−0%) | $20.95 | $6K | -12.2% | — |
| Aug 10SEC | Larry L WoodCEO, President | Buy | 23,900new position | $20.85 | $498K | -11.8% | — |
| Jun 10SEC | Barry L TemplinCTO | Sell | 35868,953 held (−1%) | $28.48 | $10K | -35.4% | — |
| Jun 10SEC | Kevin WatersCFO | Sell | 357151,201 held (−0%) | $28.48 | $10K | -35.4% | — |
| Jun 10SEC | Alaleh NouriGeneral Counsel | Sell | 285105,069 held (−0%) | $28.48 | $8K | -35.4% | — |
| Mar 19SEC | Alaleh NouriGeneral Counsel | Sell Plan | 3,031107,686 held (−3%) | $25.82 | $78K | -28.7% | — |
| Mar 19SEC | Alaleh NouriGeneral Counsel | Sell Plan | 2,332105,354 held (−2%) | $26.15 | $61K | -29.6% | — |
| Mar 19SEC | Kevin WatersCFO | Sell | 706151,558 held (−0%) | $28.15 | $20K | -34.6% | — |
| Mar 19SEC | Alaleh NouriGeneral Counsel | Sell | 304110,717 held (−0%) | $28.15 | $9K | -34.6% | — |
| Mar 12SEC | Alaleh NouriGeneral Counsel | Sell Plan | 3,098111,166 held (−3%) | $25.60 | $79K | -28.1% | — |
| Mar 12SEC | Alaleh NouriGeneral Counsel | Sell Plan | 145111,021 held (−0%) | $26.74 | $4K | -31.2% | — |
| Mar 9SEC | Antal Rohit DesaiDirector | Buy | 142,498new position | $25.44 | $3.6M | -27.7% | — |
| Mar 9SEC | Antal Rohit DesaiDirector | Buy | 106,554273,800 held (+64%) | $23.33 | $2.5M | -21.1% | — |
| Mar 9SEC | Antal Rohit DesaiDirector | Buy | 53,818424,962 held (+15%) | $24.91 | $1.3M | -26.1% | — |
| Mar 9SEC | Antal Rohit DesaiDirector | Buy | 53,763327,563 held (+20%) | $24.10 | $1.3M | -23.7% | — |
| Mar 9SEC | Antal Rohit DesaiDirector | Buy | 43,581371,144 held (+13%) | $24.08 | $1.0M | -23.6% | — |
| Mar 9SEC | Antal Rohit DesaiDirector | Buy | 24,748167,246 held (+17%) | $26.41 | $654K | -30.3% | — |
| Mar 9SEC | Alaleh NouriGeneral Counsel | Sell | 6,892114,264 held (−6%) | $23.70 | $163K | -22.4% | — |
| Mar 9SEC | Kevin WatersCFO | Sell | 6,721152,264 held (−4%) | $23.70 | $159K | -22.4% | — |
| Mar 9SEC | Antal Rohit DesaiDirector | Buy | 1,300426,262 held (+0%) | $25.42 | $33K | -27.6% | — |
Insiders at PROCEPT BioRobotics Corp
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Antal Rohit DesaiDirector | $10.5M | — | Mar 9, 2026 | — |
| Larry L WoodCEO, President | $498K | — | Aug 10, 2026 | — |
| Alaleh NouriGeneral Counsel | — | $409K | Sep 10, 2026 | — |
| Kevin WatersCFO | — | $197K | Sep 10, 2026 | — |
| Barry L TemplinCTO | — | $18K | Sep 10, 2026 | — |
PRCT stock: common questions
Are PROCEPT BioRobotics Corp insiders buying PRCT stock?
In the past 12 months, 2 insiders reported open-market purchases of PRCT worth $11.0M. The latest was CEO, President Larry L Wood bought $498K of PRCT at $20.85 — first open-market purchase in our records; opens a new position.
Are PROCEPT BioRobotics Corp insiders selling PRCT stock?
3 insiders reported sales worth $624K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PRCT's 52-week range?
Over the past year PRCT has traded between $16.69 and $36.95. It last closed at $18.40 on Oct 9, 2026.